AJAlan Jones

Alan Jones

*This is an algorithmically generated author record based on publicly available information.

Alan Jones has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Critical review of chronic toxicity testing approaches with the saltwater mysid (Americamysis bahia) used in pesticide registration

    by Margaret Fleming, Jane Staveley, Alan Samel, John Aufderheide, T Michelle Blickley, Audrey Bone, Eric Bruns, Tara Catron, Daniel Edwards, Sean Gallagher, et al.

    The United States Environmental Protection Agency (USEPA) has a conditional requirement for a chronic toxicity test with mysids (Americamysis bahia) for registration of pesticide products. Achieving performance acceptability criteria in control treatments for this study can be challenging because the current draft test guideline, which was published in 1996 under USEPA Office of Prevention, Pesticides, and Toxic Substances (OPPTS) 850.1350, Mysid Chronic Toxicity Test, provides limited information on study design and conduct. This critical review was undertaken to (1) identify areas of inconsistency in acceptability criteria between the 1996 draft OPPTS test guideline and ASTM International test guidance, (2) highlight areas that require additional clarification, (3) discuss areas that are impractical or have uncertain scientific relevance regarding the objectives of the test, and (4) provide recommendations for revision of the draft OPPTS test guideline. To achieve this, 116 final study reports from chronic mysid toxicity tests conducted over approximately the past 30 years were collected. From these reports, survival, growth, and reproduction data from negative and solvent control groups were compiled. Through investigation of trends in the data, it became apparent that no-observed-effect concentrations (NOECs) were most commonly based on reproductive endpoints, followed by adult growth endpoints and adult survival. Notably, less than 1% of studies had a NOEC based solely on a second-generation measurement endpoint. Analysis of this comprehensive data set provided clarity on the establishment of acceptability criteria for the study and elements of the testing procedure that can be streamlined without loss of critical information, which resulted in a set of recommendations to improve future versions of the chronic mysid toxicity test guideline.


  • Open Access

    Recent Developments in Sediment Toxicity Testing

    by Michiel T. O. Jonker, Alan J. Jones


  • A Comparison of In Vitro Metabolic Clearance of Various Regulatory Fish Species Using Hepatic S9 Fractions

    by Megan Zercher, Jason A. Coral, Diane Nabb, Griselda Powers, Alan Jones, Karla Johanning

    Bioaccumulation predictions can be substantially improved by combining in vitro metabolic rate measurements derived from rainbow trout hepatocytes and/or hepatic S9 fractions with quantitative structure–activity relationship (QSAR) modeling approaches. Compared with in vivo testing guidelines Organisation for Economic Co-operation and Development (OECD) 305 and Office of Chemical Safety and Pollution Prevention (OCSPP; an office of the US Environmental Protection Agency) 850.1730, the recently adopted OECD test guidelines 319A and 319B are in vitro approaches that have the potential to provide a time- and cost-efficient, humane solution, reducing animal use while addressing uncertainties in bioaccumulation across species. The present study compares the hepatic clearance of the S9 subcellular fraction of rainbow trout, bluegill, common carp, fathead minnow, and largemouth bass, discerning potential differences in metabolism between different warm- and cold-water species. With refinements to the in vitro metabolic S9 assay for high-throughput analysis, we measured in vitro clearance rates of seven chemicals crossing multiple classes of chemistry and modes of action. We confirmed that data from rainbow trout liver S9 fraction metabolic rates can be utilized to predict rainbow trout bioconcentration factors using an in vitro to in vivo extrapolation model, as intended in the OECD 319B applicability domain per the bioaccumulation prediction. Also, we determined that OECD 319B can be applied to other species, modified according to their habitat, adaptations to feeding behavior, and environmental conditions (e.g., temperature). Once toxicokinetics for each species is better understood and appropriate models are developed, this method can be an excellent tool to determine hepatic clearance and potential bioaccumulation across species. The present study could be leveraged prior to or in place of initiating in vivo bioconcentration studies, thus optimizing selection of appropriate fish species. Environ Toxicol Chem 2024;43:1390–1405. © 2024 SETAC Flowchart of methods employed for in vitro metabolism assessment in multiple fish species of regulatory relevance. NADPH = reduced nicotinamide adenine dinucleotide phosphate; GSH = glutathione; UDPGA = uridine diphosphate glucuronic acid; PAPS = 3′-phosphoadenosine-5′-phosphosulfate; std = standard; OECD TG = Organisation for Economic Co-operation and Development test guideline.


  • Open Access

    Detection of anti-androgenic activity of chemicals in fish studies: a data review

    by Grace H. Panter, Rebecca J. Brown, Alan Jones, Oliver Körner, Laurent Lagadic, Lennart Weltje

    A systematic review was conducted on the sensitivity of fish testing guidelines to detect the anti-androgenic activity of substances. Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS) was used to investigate the conservation of the androgen receptor (AR) between humans and fish, and among fish species recommended in test guidelines. The AR is conserved between fish species and humans (i.e. ligand binding domain [LBD] homology ≥70%) and among the recommended fish species (LBD homology >85%). For model anti-androgens, we evaluated literature data on in vitro anti-androgenic activity in fish-specific receptor-based assays and changes in endpoints indicative of endocrine modulation from in vivo studies. Anti-androgenic activity was most consistently and reliably detected in in vitro and in vivo mechanistic studies with co-exposure to an androgen (spiggin in vitro assay, Rapid Androgen Disruption Activity Reporter [RADAR] Assay, and Androgenised Female Stickleback Screen). Regardless of study design (Fish Short-Term Reproduction Assay [FSTRA], Fish Sexual Development Test [FSDT], partial or full life-cycle tests), or endpoint (vitellogenin, secondary sexual characteristics, gonadal histopathology, sex ratio), there was no consistent evidence for detecting anti-androgenic activity in studies without androgen co-exposure, even for the most potent substances (while less potent substances may induce no (clear) response). Therefore, based on studies without androgen co-exposure (35 FSTRAs and 22 other studies), the other studies (including the FSDT) do not outperform the FSTRA for detecting potent anti-androgenic activity, which if suspected, would be best addressed with a RADAR assay. Overall, fish do not appear particularly sensitive to mammalian anti-androgens.


  • Open Access

    Evaluating the Functional Equivalency of Test Organism Performance in Negative and Solvent Controls During Chronic Sediment Ecotoxicity Studies Based on US Environmental Protection Agency Guidance

    by Theodore Valenti, Kent Kabler, David Dreier, Kevin Henry, Alan Jones, Matt McCoole, Mark Cafarella, Jennifer Collins, Michael Bradley, Alan Samel, et al.

    The US Environmental Protection Agency (USEPA) considers sediment toxicity tests as conditional registration requirements for pesticides with soil Kd ≥50 L/kg-solid, Koc ≥1000 L/kg-organic carbon, or log Kow ≥3. The hydrophobicity of these compounds often necessitates use of solvents to ensure accurate and homogeneous dosing of spiked-sediment studies. For sediment tests, a volatile solvent (e.g., acetone) is generally used as a transient carrier. Due to low water solubility, test material is dissolved in a volatile solvent to create stock solutions. A measured aliquot of stock solution is then mixed with sand substrate, after which the solvent is evaporated. This spiking process results in negligible solvent exposure to organisms. In 2016, USEPA released final ecotoxicity test guidelines for subchronic freshwater (850.1735) and marine (850.1740) sediment test. These methods provide an option for conducting experiments with only a solvent control and no negative control. To adopt this testing strategy, functional equivalency between the negative and solvent control must be demonstrated. These test guidelines describe specific factors that should be considered for evaluating functional equivalency, including (a) the concentration of solvent in the test sediment after evaporation, (b) the levels of solvent that are known to affect organism health, (c) the known impurities in the solvent and their potential impact on organism health, and (d) the historical organism performance of solvent versus negative controls. Our analysis considers these factors and overall supports the elimination of the negative control requirement because this change is unlikely to impact the robustness or interpretability of spiked-sediment toxicity tests. Environ Toxicol Chem 2024;43:1740–1746. © 2023 CropLife America. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.